# The Role of Amylin in Bone Metabolism

> **NCT06186063** · NA · UNKNOWN · sponsor: **Filip Krag Knop** · enrollment: 20 (estimated)

## Conditions studied

- Bone Diseases, Metabolic
- Type 1 Diabetes

## Interventions

- **OTHER:** Pramlintide
- **OTHER:** Placebo (saline) infusion

## Key facts

- **NCT ID:** NCT06186063
- **Lead sponsor:** Filip Krag Knop
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-12
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186063, "The Role of Amylin in Bone Metabolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06186063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*